Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1741)	7/19/2007 12:07:58 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CYTR Has continued the near term UT that started on Jul 3 from the $3.15 level. It has closed its Jul 9 UG & is starting to get off from its intermediate term DT coming from the Apr 4 H at 5.36 bigcharts.marketwatch.com The 1st Q results showed a triple digits improvement on revenues for the 3rd time on a roll & the company has continued to trim its losses. The CEO stated that with the recent financing in April,they are making preparations to move into potential clinical development for stroke recovery and to start a PIIb in ALS latter this Yr. In January, they contributed its RNAi assets to they new subsidiary, RXi, which is now one of the few companies focused exclusively on developing products based on RNAi technology. I started a position on CYTR this month, since I had good results with RNAI & I like the roster of institutional holders in CYTR.<g> The stock needs to close above $4.25 before I will add to my position. bigcharts.marketwatch.com If the stock can close above $5, it has room torun.<g> bigcharts.marketwatch.com Bernard